MRNA240816P76000
- 0.29
- +0.11+61.11%
Moderna Newsroom
Market Whales and Their Recent Bets on MRNA Options
The Rise of OpenAI and Microsoft's $13 Billion Bet on the AI Startup
Express News | Moderna : Leerink Partners Raises Target Price to $58 From $56
The Zacks Analyst Blog Vertex Pharmaceuticals CRISPR and Moderna
10 Health Care Stocks Whale Activity In Today's Session
Over 50% of the Nasdaq-100 Names Trade Below Their 200-day Moving Average
Express News | Africa CDC Plans To Declare Regional Mpox Outbreak An Emergency
Unusual Options Activity: GOLD, ARCC and Others Attract Market Bets, GOLD V/OI Ratio Reaches 166.7
What the Options Market Tells Us About Moderna
Deutsche Bank Upgrades Moderna to Hold From Sell, Adjusts Price Target to $80 From $85
Express News | Deutsche Bank Upgrades Moderna to Hold, Lowers Price Target to $80
When Product Launches Struggle, Biotech Investors Reward Cost Cuts -- WSJ
Moderna, Inc. (NASDAQ:MRNA) Analysts Are More Bearish Than They Used To Be
Express News | Arbutus Biopharma Corp - Requesting Amended Case Schedule to Accommodate Certain Outstanding Discovery From Moderna and Third Parties
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,300 Today
Express News | Moderna Shares Are Trading Lower After RBC Capital Downgraded the Stock From Outperform to Sector Perform and Lowered Its Price Target From $125 to $90
Sector Update: Health Care Stocks Fall in Afternoon Trading
Sector Update: Health Care
'WHO Warns On Deadlier Strain Of Mpox' - Axios
Moderna Facing Headwinds for Respiratory Syncytial Virus, COVID Vaccines, RBC Says